CHRT.LSE

For the fiscal year ending April 30, 2027, Cohort plc's Total Revenue needs to exceed £330 million, representing year-over-year growth of at least 9% from the reported £303 million in FY26. This would significantly beat the current analyst consensus estimate of approximately £314.8 million for FY27 and demonstrate sustained momentum following the 12% growth achieved in FY26.

Exceeding this revenue threshold would confirm Cohort's ability to capitalize on increased global defense spending and technological modernization, validating its investment thesis. It would signal robust demand for its specialized defense electronics and services, strengthening its competitive position and potentially leading to an upward revaluation of the stock.

Order Intake growth of 15%+ year-over-year for the upcoming financial year (FY2027), or a book-to-bill ratio of 1.2x or higher, coupled with management providing an even more bullish outlook on the future order pipeline and conversion.

Achieving this threshold would signal Cohort's accelerated capture of increasing global defense spending and its ability to outperform peers in a robust market. This demonstrates strong competitive positioning and future revenue visibility, justifying a higher valuation multiple as it confirms the core investment thesis of 'Modern Warfare '26' themes.

For Cohort plc to rerate higher, the company would need to report an Adjusted Operating Profit for the financial year ending April 30, 2027, that significantly exceeds the current analyst consensus of approximately £41.0m - £41.1m. This would imply an Adjusted Operating Profit Margin of 13.5% or higher, a notable increase from the 11.9% achieved in FY26. Additionally, demonstrating strong cash flow generation, particularly after the slight miss in net funds for FY26 due to timing, would be crucial. Continued strong order intake and clear progress in improving the net margin of the Sensors and Effectors division towards its mid-term target would also contribute positively to a rerating.

Achieving an Adjusted Operating Profit above current consensus and an Adjusted Operating Profit Margin of 13.5% or higher would signal enhanced operational efficiency and successful execution of Cohort's growth strategy. This demonstrates the company's ability to capitalize on the robust global defense spending environment and translate its record order book into higher profitability, validating the investment thesis and potentially leading to a higher valuation multiple.